AbTis | 앱티스
Bridging Life and Science with Innovative Linker Technology
Bridging Life and Science with Innovative Linker Technology
AbTis Co., Ltd. is a leading ADC Biotech Company based in Korea South, founded in 2016. Known for its slogan "ADC 플랫폼 및 파이프라인 개발" which translates to "ADC platform and pipeline development," the company boasts of world-class platform technology. In its latest funding round, AbTis Co., Ltd. secured a significant KRW15.00B Series B investment on 02 February 2021. This substantial investment was backed by a group of prominent investors including Aju IB Investment, K2 Investment Partners, Prodigy Investment, Stonebridge Ventures, Timefolio Asset Management, Kingo Investment Partners, and KDB Industrial Bank.
Specializing in the Biotechnology and Health Care industries, AbTis Co., Ltd. is dedicated to advancing the field of ADC biotechnology. With its strong financial backing and a clear focus on groundbreaking technology, the company is well-positioned to make a significant impact in the biotech sector and beyond.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Series B | KRW15.00B | 7 |
|
02 Feb 2021 |
We care about your data, and we'd love to use cookies make your experience better.